Diclazuril

From WikiMD's WELLNESSPEDIA

(Redirected from Vecoxan)

Diclazuril


Diclazuril is an antiprotozoal agent used primarily in the treatment of coccidiosis, a parasitic disease affecting a variety of animals. It is a member of the benzeneacetonitrile group of compounds and is commercially available under various trade names, including Clinacox, Vecoxan, and Tolcox.

Chemistry[edit]

Diclazuril is a synthetic compound with the chemical formula C17H9Cl3N4O2. It is a white, crystalline powder that is slightly soluble in water and most organic solvents. The compound's structure includes a triazinone ring, which is believed to be responsible for its antiprotozoal activity.

Mechanism of Action[edit]

The exact mechanism of action of diclazuril is not fully understood. However, it is believed to inhibit the nuclear division and wall-forming bodies in the protozoa, leading to their death. Diclazuril is effective against all intracellular developmental stages of Eimeria, the genus of parasites that cause coccidiosis.

Uses[edit]

Diclazuril is used in veterinary medicine to control and treat coccidiosis in poultry, rabbits, calves, lambs, and goats. It is administered orally, usually mixed with feed, and is effective against a broad spectrum of Eimeria species.

Safety and Side Effects[edit]

Diclazuril is generally considered safe for use in animals. However, some side effects, such as reduced feed intake and weight gain, have been reported. As with all medications, it should be used under the supervision of a veterinarian.

Regulation[edit]

In many countries, the use of diclazuril in food-producing animals is regulated to prevent residues in food products. Withdrawal periods, the time between the last administration of the drug and the slaughter of the animal for food, are established to ensure that residues are below the maximum residue limit.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.